IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: ALTERNATIVE TREATMENT OF PARKINSONS DISEASE: A REVIEW
Authors Name: Mohammed Mudassir , Aamir Khan Yusuf Khan , Nazneen Begum
Download E-Certificate: Download
Author Reg. ID:
IJNRD_184153
Published Paper Id: IJNRD2211204
Published In: Volume 7 Issue 11, November-2022
DOI:
Abstract: Parkinson’s disease typically develops between the ages of 55 and 65 years and occurs in 1 to 2% of persons over the age of 60 years. Approximately 0.3% of the general population is affected, and the prevalence is higher among men than women, with a ratio of 1.6 to 1.0. As the population ages, the incidence of PD is expected to increase dramatically in the coming decades. Current therapies are largely based on dopamine replacement strategies using the dopamine precursor levodopa. However, chronic treatment is accompanied by the development of motor complications and the disease progresses inexorably. Moreover, disease progression is associated with the emergence of symptoms such as freezing, falls, and dementia that cannot be adequately controlled with dopaminergic therapy. Indeed, these non-dopaminergic traits are now recognized to be common and a major cause of disability in patients with progressive disease. Many different treatments and therapeutic strategies have been evaluated, and many promising approaches are currently being tested in the laboratory and clinic. As a result, many new therapeutics and strategic approaches to treat different stages of Parkinson's disease have become available. Treatment for Parkinson's disease typically involves a combination of treatments. An important part of Parkinson's disease treatment is drug therapy supported by various combination therapies. Treatment is primarily aimed at relieving symptoms and side effects, as the disease itself cannot currently be cured. Each Parkinson's disease course is different, and the type and severity of symptoms vary widely. What is particularly worrying to one person may not be noticed by another. In addition to symptoms, medical history, age, and living environment also play an important role. Therefore, individualized treatment is necessary.
Keywords: Parkinson's disease, neurodegenerative disorders, dopamine, levodopa, dopaminergic therapy, dementia, non-dopaminergic traits, medical history, combination therapies, etc.
Cite Article: "ALTERNATIVE TREATMENT OF PARKINSONS DISEASE: A REVIEW", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.c18-c37, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211204.pdf
Downloads: 000118745
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2211204
Registration ID: 184153
Published In: Volume 7 Issue 11, November-2022
DOI (Digital Object Identifier):
Page No: c18-c37
Country: Hyderabad, Telangana, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2211204
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2211204
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD